World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
41307
World Ranking
15859
National Ranking
600

Overview

Sjoerd Rodenhuis is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands. Their research primarily spans the field of Medicine, with a focus on several subfields including Epidemiology, Oncology, Pathology and Forensic Medicine, Surgery, and Cancer Research.

Their academic work covers main topics such as:

  • Cervical Cancer and HPV Research
  • Genetic factors in colorectal cancer
  • Colorectal and Anal Carcinomas
  • Breast Cancer Treatment Studies
  • Cancer Treatment and Pharmacology
  • HER2/EGFR in Cancer Research

Rodenhuis has contributed to a number of publications, with recent papers including:

  • Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site (2020) in British Journal of Cancer
  • Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer (2020) in UNC Libraries
  • Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site (2023) in British Journal of Cancer

The frequent coauthors collaborating with Rodenhuis include:

  • Maud Kamal
  • Sonia Lameiras
  • Marc Deloger
  • Adeline Morel
  • Sophie Vacher

The primary venues for their research publications have been:

  • British Journal of Cancer
  • UNC Libraries

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

    Marc J. van de Vijver;Yudong D. He;Laura J. van 't Veer;Hongyue Dai

  • Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy

    F.S.A.M. van Dam;S.B. Schagen;M.J. Muller;W. Boogerd

  • Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.

    S Rodenhuis;M L van de Wetering;W J Mooi;S G Evers

  • Incidence and Possible Clinical Significance of K- ras Oncogene Activation in Adenocarcinoma of the Human Lung

    S. Rodenhuis;R. J. C. Slebos;A. J. M. Boot;S. G. Evers

  • Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study.

    J Verweij;A van Oosterom;J.-Y Blay;I Judson

  • Clinical Pharmacokinetics of Cyclophosphamide

    Milly E de Jonge;Alwin D R Huitema;Sjoerd Rodenhuis;Jos H Beijnen

  • Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial

    A. Le Cesne;J.Y. Blay;I. Judson;A. Van Oosterom

  • Clinical significance of ras oncogene activation in human lung cancer.

    Sjoerd Rodenhuis;Robert J. C. Slebos

  • Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

    I F Faneyte;J G Schrama;J L Peterse;P L Remijnse

  • Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

    Sjoerd Rodenhuis;Dick J. Richel;Elsken Van Der Wall;Jan H. Schornagel

  • Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

    Paul C Lorigan;Jaap Verweij;Zsuzsa Papai;Sjoerd Rodenhuis

  • Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)

    Jolien M. Bueno-de-Mesquita;Wim H. van Harten;Valesca P. Retel;Laura J. van't Veer

  • Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype

    Claudette E. Loo;Marieke E. Straver;Sjoerd Rodenhuis;Sara H. Muller

  • The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

    Marieke E. Straver;Annuska M. Glas;Juliane Hannemann;Jelle Wesseling

  • High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer

    Sjoerd Rodenhuis;Marijke Bontenbal;Louk V.A.M. Beex;John Wagstaff

  • Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group.

    A. Le Cesne;I. Judson;D. Crowther;S. Rodenhuis

  • Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients

    S. B. Schagen;M. J. Muller;W. Boogerd;R. M. Rosenbrand

  • Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).

    Stefan Sleijfer;Monia Ouali;Martine van Glabbeke;Anders Krarup-Hansen

  • Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.

    R J Slebos;R H Hruban;O Dalesio;W J Mooi

Frequent Co-Authors

Jos H. Beijnen
Jos H. Beijnen Utrecht University
Jelle Wesseling
Jelle Wesseling Leiden University Medical Center
Emiel J. Th. Rutgers
Emiel J. Th. Rutgers Antoni van Leeuwenhoek Hospital
Jan H.M. Schellens
Jan H.M. Schellens Utrecht University
Lodewyk F. A. Wessels
Lodewyk F. A. Wessels Antoni van Leeuwenhoek Hospital
Johannes L. Peterse
Johannes L. Peterse Antoni van Leeuwenhoek Hospital
Marc J. van de Vijver
Marc J. van de Vijver University of Amsterdam
Elisabeth G.E. de Vries
Elisabeth G.E. de Vries University Medical Center Groningen
Emile E. Voest
Emile E. Voest Antoni van Leeuwenhoek Hospital
Hilde Rosing
Hilde Rosing Antoni van Leeuwenhoek Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine or healthcare opens up a variety of academic and professional pathways—many of which can now be started online. For registered nurses looking to boost their qualifications, enrolling in the cheapest rn to bsn program online can be a smart, cost-effective step toward advancing your career.

If you hold a non-nursing bachelor’s degree but want to make a rapid transition into nursing, consider pursuing a non nursing bachelor's to msn online program. These programs are designed for career-changers eager to enter the nursing field efficiently and effectively.

Students who prefer clear, direct access to a nursing career may benefit from direct admit nursing programs, which streamline the path into clinical education for eligible applicants.

For those interested in the administrative side of healthcare, enrolling in one of the best medical billing and coding schools online with financial aid options can provide a flexible and in-demand career pathway.

Best Scientists Citing Sjoerd Rodenhuis

Trending Scientists